Global Cell and Gene Therapy Market Growth (Status and Outlook) 2026-2032
The global Cell and Gene Therapy market size is predicted to grow from US$ 3502 million in 2025 to US$ 5670 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.
Cell and Gene Therapy is a revolutionary medical technology that treats or cures diseases by modifying or manipulating human genes. Its core lies in intervening at the root causes of genetic defects, cancer, and chronic diseases. This therapy is mainly divided into two categories: gene therapy focuses on delivering functionally normal genes into the patient's body via viral or non-viral vectors to replace or compensate for defective/abnormal genes, or to silence the expression of harmful genes; cell therapy involves modifying, activating, or expanding autologous or allogeneic live cells (such as immune cells and stem cells) in vitro and then reinfusing them to rebuild immune function, repair damaged tissue, or directly kill tumors. As a cutting-edge field of precision medicine, Cell and Gene Therapy offers potential cures for many diseases that traditional therapies have failed to address.
The global cell and gene therapy market is experiencing rapid growth driven by technological breakthroughs, a surge in pipelines, and commercialization. North America and Europe, as mature markets, lead in the number of approved CAR-T therapies, AAV gene therapies, and rare disease drugs, leveraging their advanced gene-editing technologies, robust regulatory frameworks, and extensive clinical research experience. The Asia-Pacific region is the fastest-growing and most active in clinical research. China, with its leading global number of cell therapy clinical studies, strong policy support, and cost advantages across its supply chain, is rapidly advancing autologous CAR-T, universal cell therapies, and gene-editing therapies, leading to the rapid rise of domestic innovative pharmaceutical companies. The industry as a whole is accelerating its evolution towards breakthroughs in solid tumors, universal off-the-shelf products, and in vivo gene editing.
LPI (LP Information)' newest research report, the “Cell and Gene Therapy Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy sales for 2026 through 2032. With Cell and Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cell and Gene Therapy is a revolutionary medical technology that treats or cures diseases by modifying or manipulating human genes. Its core lies in intervening at the root causes of genetic defects, cancer, and chronic diseases. This therapy is mainly divided into two categories: gene therapy focuses on delivering functionally normal genes into the patient's body via viral or non-viral vectors to replace or compensate for defective/abnormal genes, or to silence the expression of harmful genes; cell therapy involves modifying, activating, or expanding autologous or allogeneic live cells (such as immune cells and stem cells) in vitro and then reinfusing them to rebuild immune function, repair damaged tissue, or directly kill tumors. As a cutting-edge field of precision medicine, Cell and Gene Therapy offers potential cures for many diseases that traditional therapies have failed to address.
The global cell and gene therapy market is experiencing rapid growth driven by technological breakthroughs, a surge in pipelines, and commercialization. North America and Europe, as mature markets, lead in the number of approved CAR-T therapies, AAV gene therapies, and rare disease drugs, leveraging their advanced gene-editing technologies, robust regulatory frameworks, and extensive clinical research experience. The Asia-Pacific region is the fastest-growing and most active in clinical research. China, with its leading global number of cell therapy clinical studies, strong policy support, and cost advantages across its supply chain, is rapidly advancing autologous CAR-T, universal cell therapies, and gene-editing therapies, leading to the rapid rise of domestic innovative pharmaceutical companies. The industry as a whole is accelerating its evolution towards breakthroughs in solid tumors, universal off-the-shelf products, and in vivo gene editing.
LPI (LP Information)' newest research report, the “Cell and Gene Therapy Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy sales for 2026 through 2032. With Cell and Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Rare Diseases
- Oncology
- Hematology
- Cardiovascular
- Ophthalmology
- Neurology
- Others
- Autologous Cell Therapy
- Universal Cell Therapy
- Xenogeneic Cell Therapy
- Viral Vector Delivery
- Non-viral Vector Delivery
- Gene Editing Technology
- Others
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutions
- Contract Research Organizations (CROs)
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc.
- Dendreon Pharmaceuticals LLC.
- Fibrocell Science, Inc
- Lonza
- Charles River Laboratories
- Cytiva
- Catalent Biologics
- FUJIFILM Diosynth Biotechnologies
- Made Scientific
- AGC Biologics
- Pfizer CentreOne
- Samsung Biologics
- Kite Pharma, Inc.
- Kolon TissueGene, Inc.
- Novartis AG
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Market Size (2021-2032)
2.1.2 Cell and Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell and Gene Therapy by Country/Region (2021, 2025 & 2032)
2.2 Cell and Gene Therapy Segment by Type
2.2.1 Rare Diseases
2.2.2 Oncology
2.2.3 Hematology
2.2.4 Cardiovascular
2.2.5 Ophthalmology
2.2.6 Neurology
2.2.7 Others
2.2.8 Cell and Gene Therapy Market Size by Type
2.2.8.1 Cell and Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
2.3 Cell and Gene Therapy Segment by Cell Source
2.3.1 Autologous Cell Therapy
2.3.2 Universal Cell Therapy
2.3.3 Xenogeneic Cell Therapy
2.3.4 Cell and Gene Therapy Market Size by Cell Source
2.3.4.1 Cell and Gene Therapy Market Size CAGR by Cell Source (2021 VS 2025 VS 2032)
2.3.4.2 Global Cell and Gene Therapy Market Size Market Share by Cell Source (2021-2026)
2.4 Cell and Gene Therapy Segment by Technology
2.4.1 Viral Vector Delivery
2.4.2 Non-viral Vector Delivery
2.4.3 Gene Editing Technology
2.4.4 Others
2.4.5 Cell and Gene Therapy Market Size by Technology
2.4.5.1 Cell and Gene Therapy Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.4.5.2 Global Cell and Gene Therapy Market Size Market Share by Technology (2021-2026)
2.5 Cell and Gene Therapy Segment by Application
2.5.1 Pharmaceutical and Biotechnology Companies
2.5.2 Research and Academic Institutions
2.5.3 Contract Research Organizations (CROs)
2.5.4 Hospital
2.5.5 Others
2.5.6 Cell and Gene Therapy Market Size by Application
2.5.6.1 Cell and Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
3 CELL AND GENE THERAPY MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy Market Size Market Share by Player
3.1.1 Global Cell and Gene Therapy Revenue by Player (2021-2026)
3.1.2 Global Cell and Gene Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY BY REGION
4.1 Cell and Gene Therapy Market Size by Region (2021-2026)
4.2 Global Cell and Gene Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Gene Therapy Market Size Growth (2021-2026)
4.4 APAC Cell and Gene Therapy Market Size Growth (2021-2026)
4.5 Europe Cell and Gene Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Gene Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell and Gene Therapy Market Size by Country (2021-2026)
5.2 Americas Cell and Gene Therapy Market Size by Type (2021-2026)
5.3 Americas Cell and Gene Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Market Size by Region (2021-2026)
6.2 APAC Cell and Gene Therapy Market Size by Type (2021-2026)
6.3 APAC Cell and Gene Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy Market Size by Country (2021-2026)
7.2 Europe Cell and Gene Therapy Market Size by Type (2021-2026)
7.3 Europe Cell and Gene Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy by Region (2021-2026)
8.2 Middle East & Africa Cell and Gene Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Gene Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY MARKET FORECAST
10.1 Global Cell and Gene Therapy Forecast by Region (2027-2032)
10.1.1 Global Cell and Gene Therapy Forecast by Region (2027-2032)
10.1.2 Americas Cell and Gene Therapy Forecast
10.1.3 APAC Cell and Gene Therapy Forecast
10.1.4 Europe Cell and Gene Therapy Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Forecast
10.2 Americas Cell and Gene Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Cell and Gene Therapy Forecast
10.2.2 Canada Market Cell and Gene Therapy Forecast
10.2.3 Mexico Market Cell and Gene Therapy Forecast
10.2.4 Brazil Market Cell and Gene Therapy Forecast
10.3 APAC Cell and Gene Therapy Forecast by Region (2027-2032)
10.3.1 China Cell and Gene Therapy Market Forecast
10.3.2 Japan Market Cell and Gene Therapy Forecast
10.3.3 Korea Market Cell and Gene Therapy Forecast
10.3.4 Southeast Asia Market Cell and Gene Therapy Forecast
10.3.5 India Market Cell and Gene Therapy Forecast
10.3.6 Australia Market Cell and Gene Therapy Forecast
10.4 Europe Cell and Gene Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Cell and Gene Therapy Forecast
10.4.2 France Market Cell and Gene Therapy Forecast
10.4.3 UK Market Cell and Gene Therapy Forecast
10.4.4 Italy Market Cell and Gene Therapy Forecast
10.4.5 Russia Market Cell and Gene Therapy Forecast
10.5 Middle East & Africa Cell and Gene Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell and Gene Therapy Forecast
10.5.2 South Africa Market Cell and Gene Therapy Forecast
10.5.3 Israel Market Cell and Gene Therapy Forecast
10.5.4 Turkey Market Cell and Gene Therapy Forecast
10.6 Global Cell and Gene Therapy Forecast by Type (2027-2032)
10.7 Global Cell and Gene Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell and Gene Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Cell and Gene Therapy Product Offered
11.1.3 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Amgen Inc. Main Business Overview
11.1.5 Amgen Inc. Latest Developments
11.2 Dendreon Pharmaceuticals LLC.
11.2.1 Dendreon Pharmaceuticals LLC. Company Information
11.2.2 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
11.2.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Dendreon Pharmaceuticals LLC. Main Business Overview
11.2.5 Dendreon Pharmaceuticals LLC. Latest Developments
11.3 Fibrocell Science, Inc
11.3.1 Fibrocell Science, Inc Company Information
11.3.2 Fibrocell Science, Inc Cell and Gene Therapy Product Offered
11.3.3 Fibrocell Science, Inc Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Fibrocell Science, Inc Main Business Overview
11.3.5 Fibrocell Science, Inc Latest Developments
11.4 Lonza
11.4.1 Lonza Company Information
11.4.2 Lonza Cell and Gene Therapy Product Offered
11.4.3 Lonza Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Lonza Main Business Overview
11.4.5 Lonza Latest Developments
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Information
11.5.2 Charles River Laboratories Cell and Gene Therapy Product Offered
11.5.3 Charles River Laboratories Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Charles River Laboratories Main Business Overview
11.5.5 Charles River Laboratories Latest Developments
11.6 Cytiva
11.6.1 Cytiva Company Information
11.6.2 Cytiva Cell and Gene Therapy Product Offered
11.6.3 Cytiva Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Cytiva Main Business Overview
11.6.5 Cytiva Latest Developments
11.7 Catalent Biologics
11.7.1 Catalent Biologics Company Information
11.7.2 Catalent Biologics Cell and Gene Therapy Product Offered
11.7.3 Catalent Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Catalent Biologics Main Business Overview
11.7.5 Catalent Biologics Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.9 Made Scientific
11.9.1 Made Scientific Company Information
11.9.2 Made Scientific Cell and Gene Therapy Product Offered
11.9.3 Made Scientific Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Made Scientific Main Business Overview
11.9.5 Made Scientific Latest Developments
11.10 AGC Biologics
11.10.1 AGC Biologics Company Information
11.10.2 AGC Biologics Cell and Gene Therapy Product Offered
11.10.3 AGC Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AGC Biologics Main Business Overview
11.10.5 AGC Biologics Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Cell and Gene Therapy Product Offered
11.11.3 Pfizer CentreOne Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Samsung Biologics
11.12.1 Samsung Biologics Company Information
11.12.2 Samsung Biologics Cell and Gene Therapy Product Offered
11.12.3 Samsung Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Samsung Biologics Main Business Overview
11.12.5 Samsung Biologics Latest Developments
11.13 Kite Pharma, Inc.
11.13.1 Kite Pharma, Inc. Company Information
11.13.2 Kite Pharma, Inc. Cell and Gene Therapy Product Offered
11.13.3 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kite Pharma, Inc. Main Business Overview
11.13.5 Kite Pharma, Inc. Latest Developments
11.14 Kolon TissueGene, Inc.
11.14.1 Kolon TissueGene, Inc. Company Information
11.14.2 Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
11.14.3 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kolon TissueGene, Inc. Main Business Overview
11.14.5 Kolon TissueGene, Inc. Latest Developments
11.15 Novartis AG
11.15.1 Novartis AG Company Information
11.15.2 Novartis AG Cell and Gene Therapy Product Offered
11.15.3 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Novartis AG Main Business Overview
11.15.5 Novartis AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Market Size (2021-2032)
2.1.2 Cell and Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell and Gene Therapy by Country/Region (2021, 2025 & 2032)
2.2 Cell and Gene Therapy Segment by Type
2.2.1 Rare Diseases
2.2.2 Oncology
2.2.3 Hematology
2.2.4 Cardiovascular
2.2.5 Ophthalmology
2.2.6 Neurology
2.2.7 Others
2.2.8 Cell and Gene Therapy Market Size by Type
2.2.8.1 Cell and Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
2.3 Cell and Gene Therapy Segment by Cell Source
2.3.1 Autologous Cell Therapy
2.3.2 Universal Cell Therapy
2.3.3 Xenogeneic Cell Therapy
2.3.4 Cell and Gene Therapy Market Size by Cell Source
2.3.4.1 Cell and Gene Therapy Market Size CAGR by Cell Source (2021 VS 2025 VS 2032)
2.3.4.2 Global Cell and Gene Therapy Market Size Market Share by Cell Source (2021-2026)
2.4 Cell and Gene Therapy Segment by Technology
2.4.1 Viral Vector Delivery
2.4.2 Non-viral Vector Delivery
2.4.3 Gene Editing Technology
2.4.4 Others
2.4.5 Cell and Gene Therapy Market Size by Technology
2.4.5.1 Cell and Gene Therapy Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.4.5.2 Global Cell and Gene Therapy Market Size Market Share by Technology (2021-2026)
2.5 Cell and Gene Therapy Segment by Application
2.5.1 Pharmaceutical and Biotechnology Companies
2.5.2 Research and Academic Institutions
2.5.3 Contract Research Organizations (CROs)
2.5.4 Hospital
2.5.5 Others
2.5.6 Cell and Gene Therapy Market Size by Application
2.5.6.1 Cell and Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
3 CELL AND GENE THERAPY MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy Market Size Market Share by Player
3.1.1 Global Cell and Gene Therapy Revenue by Player (2021-2026)
3.1.2 Global Cell and Gene Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY BY REGION
4.1 Cell and Gene Therapy Market Size by Region (2021-2026)
4.2 Global Cell and Gene Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Gene Therapy Market Size Growth (2021-2026)
4.4 APAC Cell and Gene Therapy Market Size Growth (2021-2026)
4.5 Europe Cell and Gene Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Gene Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell and Gene Therapy Market Size by Country (2021-2026)
5.2 Americas Cell and Gene Therapy Market Size by Type (2021-2026)
5.3 Americas Cell and Gene Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Market Size by Region (2021-2026)
6.2 APAC Cell and Gene Therapy Market Size by Type (2021-2026)
6.3 APAC Cell and Gene Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy Market Size by Country (2021-2026)
7.2 Europe Cell and Gene Therapy Market Size by Type (2021-2026)
7.3 Europe Cell and Gene Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy by Region (2021-2026)
8.2 Middle East & Africa Cell and Gene Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Gene Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY MARKET FORECAST
10.1 Global Cell and Gene Therapy Forecast by Region (2027-2032)
10.1.1 Global Cell and Gene Therapy Forecast by Region (2027-2032)
10.1.2 Americas Cell and Gene Therapy Forecast
10.1.3 APAC Cell and Gene Therapy Forecast
10.1.4 Europe Cell and Gene Therapy Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Forecast
10.2 Americas Cell and Gene Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Cell and Gene Therapy Forecast
10.2.2 Canada Market Cell and Gene Therapy Forecast
10.2.3 Mexico Market Cell and Gene Therapy Forecast
10.2.4 Brazil Market Cell and Gene Therapy Forecast
10.3 APAC Cell and Gene Therapy Forecast by Region (2027-2032)
10.3.1 China Cell and Gene Therapy Market Forecast
10.3.2 Japan Market Cell and Gene Therapy Forecast
10.3.3 Korea Market Cell and Gene Therapy Forecast
10.3.4 Southeast Asia Market Cell and Gene Therapy Forecast
10.3.5 India Market Cell and Gene Therapy Forecast
10.3.6 Australia Market Cell and Gene Therapy Forecast
10.4 Europe Cell and Gene Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Cell and Gene Therapy Forecast
10.4.2 France Market Cell and Gene Therapy Forecast
10.4.3 UK Market Cell and Gene Therapy Forecast
10.4.4 Italy Market Cell and Gene Therapy Forecast
10.4.5 Russia Market Cell and Gene Therapy Forecast
10.5 Middle East & Africa Cell and Gene Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell and Gene Therapy Forecast
10.5.2 South Africa Market Cell and Gene Therapy Forecast
10.5.3 Israel Market Cell and Gene Therapy Forecast
10.5.4 Turkey Market Cell and Gene Therapy Forecast
10.6 Global Cell and Gene Therapy Forecast by Type (2027-2032)
10.7 Global Cell and Gene Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell and Gene Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Cell and Gene Therapy Product Offered
11.1.3 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Amgen Inc. Main Business Overview
11.1.5 Amgen Inc. Latest Developments
11.2 Dendreon Pharmaceuticals LLC.
11.2.1 Dendreon Pharmaceuticals LLC. Company Information
11.2.2 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
11.2.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Dendreon Pharmaceuticals LLC. Main Business Overview
11.2.5 Dendreon Pharmaceuticals LLC. Latest Developments
11.3 Fibrocell Science, Inc
11.3.1 Fibrocell Science, Inc Company Information
11.3.2 Fibrocell Science, Inc Cell and Gene Therapy Product Offered
11.3.3 Fibrocell Science, Inc Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Fibrocell Science, Inc Main Business Overview
11.3.5 Fibrocell Science, Inc Latest Developments
11.4 Lonza
11.4.1 Lonza Company Information
11.4.2 Lonza Cell and Gene Therapy Product Offered
11.4.3 Lonza Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Lonza Main Business Overview
11.4.5 Lonza Latest Developments
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Information
11.5.2 Charles River Laboratories Cell and Gene Therapy Product Offered
11.5.3 Charles River Laboratories Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Charles River Laboratories Main Business Overview
11.5.5 Charles River Laboratories Latest Developments
11.6 Cytiva
11.6.1 Cytiva Company Information
11.6.2 Cytiva Cell and Gene Therapy Product Offered
11.6.3 Cytiva Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Cytiva Main Business Overview
11.6.5 Cytiva Latest Developments
11.7 Catalent Biologics
11.7.1 Catalent Biologics Company Information
11.7.2 Catalent Biologics Cell and Gene Therapy Product Offered
11.7.3 Catalent Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Catalent Biologics Main Business Overview
11.7.5 Catalent Biologics Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.9 Made Scientific
11.9.1 Made Scientific Company Information
11.9.2 Made Scientific Cell and Gene Therapy Product Offered
11.9.3 Made Scientific Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Made Scientific Main Business Overview
11.9.5 Made Scientific Latest Developments
11.10 AGC Biologics
11.10.1 AGC Biologics Company Information
11.10.2 AGC Biologics Cell and Gene Therapy Product Offered
11.10.3 AGC Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AGC Biologics Main Business Overview
11.10.5 AGC Biologics Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Cell and Gene Therapy Product Offered
11.11.3 Pfizer CentreOne Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Samsung Biologics
11.12.1 Samsung Biologics Company Information
11.12.2 Samsung Biologics Cell and Gene Therapy Product Offered
11.12.3 Samsung Biologics Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Samsung Biologics Main Business Overview
11.12.5 Samsung Biologics Latest Developments
11.13 Kite Pharma, Inc.
11.13.1 Kite Pharma, Inc. Company Information
11.13.2 Kite Pharma, Inc. Cell and Gene Therapy Product Offered
11.13.3 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kite Pharma, Inc. Main Business Overview
11.13.5 Kite Pharma, Inc. Latest Developments
11.14 Kolon TissueGene, Inc.
11.14.1 Kolon TissueGene, Inc. Company Information
11.14.2 Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
11.14.3 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kolon TissueGene, Inc. Main Business Overview
11.14.5 Kolon TissueGene, Inc. Latest Developments
11.15 Novartis AG
11.15.1 Novartis AG Company Information
11.15.2 Novartis AG Cell and Gene Therapy Product Offered
11.15.3 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Novartis AG Main Business Overview
11.15.5 Novartis AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell and Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Gene Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Rare Diseases
Table 4. Major Players of Oncology
Table 5. Major Players of Hematology
Table 6. Major Players of Cardiovascular
Table 7. Major Players of Ophthalmology
Table 8. Major Players of Neurology
Table 9. Major Players of Others
Table 10. Cell and Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Table 13. Major Players of Autologous Cell Therapy
Table 14. Major Players of Universal Cell Therapy
Table 15. Major Players of Xenogeneic Cell Therapy
Table 16. Cell and Gene Therapy Market Size CAGR by Cell Source (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Cell and Gene Therapy Market Size by Cell Source (2021-2026) & ($ millions)
Table 18. Global Cell and Gene Therapy Market Size Market Share by Cell Source (2021-2026)
Table 19. Major Players of Viral Vector Delivery
Table 20. Major Players of Non-viral Vector Delivery
Table 21. Major Players of Gene Editing Technology
Table 22. Major Players of Others
Table 23. Cell and Gene Therapy Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Cell and Gene Therapy Market Size by Technology (2021-2026) & ($ millions)
Table 25. Global Cell and Gene Therapy Market Size Market Share by Technology (2021-2026)
Table 26. Cell and Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 28. Global Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Table 29. Global Cell and Gene Therapy Revenue by Player (2021-2026) & ($ millions)
Table 30. Global Cell and Gene Therapy Revenue Market Share by Player (2021-2026)
Table 31. Cell and Gene Therapy Key Players Head office and Products Offered
Table 32. Cell and Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Mergers & Acquisitions, Expansion
Table 35. Global Cell and Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Global Cell and Gene Therapy Market Size Market Share by Region (2021-2026)
Table 37. Global Cell and Gene Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 38. Global Cell and Gene Therapy Revenue Market Share by Country/Region (2021-2026)
Table 39. Americas Cell and Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 40. Americas Cell and Gene Therapy Market Size Market Share by Country (2021-2026)
Table 41. Americas Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 42. Americas Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Table 43. Americas Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 44. Americas Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Table 45. APAC Cell and Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 46. APAC Cell and Gene Therapy Market Size Market Share by Region (2021-2026)
Table 47. APAC Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 48. APAC Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 49. Europe Cell and Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 50. Europe Cell and Gene Therapy Market Size Market Share by Country (2021-2026)
Table 51. Europe Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 52. Europe Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 53. Middle East & Africa Cell and Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 54. Middle East & Africa Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 55. Middle East & Africa Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 56. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy
Table 57. Key Market Challenges & Risks of Cell and Gene Therapy
Table 58. Key Industry Trends of Cell and Gene Therapy
Table 59. Global Cell and Gene Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 60. Global Cell and Gene Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 61. Global Cell and Gene Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 62. Global Cell and Gene Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 63. Amgen Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 64. Amgen Inc. Cell and Gene Therapy Product Offered
Table 65. Amgen Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Amgen Inc. Main Business
Table 67. Amgen Inc. Latest Developments
Table 68. Dendreon Pharmaceuticals LLC. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 69. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
Table 70. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Dendreon Pharmaceuticals LLC. Main Business
Table 72. Dendreon Pharmaceuticals LLC. Latest Developments
Table 73. Fibrocell Science, Inc Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 74. Fibrocell Science, Inc Cell and Gene Therapy Product Offered
Table 75. Fibrocell Science, Inc Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Fibrocell Science, Inc Main Business
Table 77. Fibrocell Science, Inc Latest Developments
Table 78. Lonza Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 79. Lonza Cell and Gene Therapy Product Offered
Table 80. Lonza Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Lonza Main Business
Table 82. Lonza Latest Developments
Table 83. Charles River Laboratories Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 84. Charles River Laboratories Cell and Gene Therapy Product Offered
Table 85. Charles River Laboratories Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Charles River Laboratories Main Business
Table 87. Charles River Laboratories Latest Developments
Table 88. Cytiva Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 89. Cytiva Cell and Gene Therapy Product Offered
Table 90. Cytiva Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Cytiva Main Business
Table 92. Cytiva Latest Developments
Table 93. Catalent Biologics Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 94. Catalent Biologics Cell and Gene Therapy Product Offered
Table 95. Catalent Biologics Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Catalent Biologics Main Business
Table 97. Catalent Biologics Latest Developments
Table 98. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 99. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Product Offered
Table 100. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. FUJIFILM Diosynth Biotechnologies Main Business
Table 102. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 103. Made Scientific Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 104. Made Scientific Cell and Gene Therapy Product Offered
Table 105. Made Scientific Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Made Scientific Main Business
Table 107. Made Scientific Latest Developments
Table 108. AGC Biologics Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 109. AGC Biologics Cell and Gene Therapy Product Offered
Table 110. AGC Biologics Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. AGC Biologics Main Business
Table 112. AGC Biologics Latest Developments
Table 113. Pfizer CentreOne Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 114. Pfizer CentreOne Cell and Gene Therapy Product Offered
Table 115. Pfizer CentreOne Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Pfizer CentreOne Main Business
Table 117. Pfizer CentreOne Latest Developments
Table 118. Samsung Biologics Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 119. Samsung Biologics Cell and Gene Therapy Product Offered
Table 120. Samsung Biologics Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Samsung Biologics Main Business
Table 122. Samsung Biologics Latest Developments
Table 123. Kite Pharma, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 124. Kite Pharma, Inc. Cell and Gene Therapy Product Offered
Table 125. Kite Pharma, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Kite Pharma, Inc. Main Business
Table 127. Kite Pharma, Inc. Latest Developments
Table 128. Kolon TissueGene, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 129. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
Table 130. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Kolon TissueGene, Inc. Main Business
Table 132. Kolon TissueGene, Inc. Latest Developments
Table 133. Novartis AG Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 134. Novartis AG Cell and Gene Therapy Product Offered
Table 135. Novartis AG Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Novartis AG Main Business
Table 137. Novartis AG Latest Developments
Table 1. Cell and Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Gene Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Rare Diseases
Table 4. Major Players of Oncology
Table 5. Major Players of Hematology
Table 6. Major Players of Cardiovascular
Table 7. Major Players of Ophthalmology
Table 8. Major Players of Neurology
Table 9. Major Players of Others
Table 10. Cell and Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Table 13. Major Players of Autologous Cell Therapy
Table 14. Major Players of Universal Cell Therapy
Table 15. Major Players of Xenogeneic Cell Therapy
Table 16. Cell and Gene Therapy Market Size CAGR by Cell Source (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Cell and Gene Therapy Market Size by Cell Source (2021-2026) & ($ millions)
Table 18. Global Cell and Gene Therapy Market Size Market Share by Cell Source (2021-2026)
Table 19. Major Players of Viral Vector Delivery
Table 20. Major Players of Non-viral Vector Delivery
Table 21. Major Players of Gene Editing Technology
Table 22. Major Players of Others
Table 23. Cell and Gene Therapy Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Cell and Gene Therapy Market Size by Technology (2021-2026) & ($ millions)
Table 25. Global Cell and Gene Therapy Market Size Market Share by Technology (2021-2026)
Table 26. Cell and Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 27. Global Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 28. Global Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Table 29. Global Cell and Gene Therapy Revenue by Player (2021-2026) & ($ millions)
Table 30. Global Cell and Gene Therapy Revenue Market Share by Player (2021-2026)
Table 31. Cell and Gene Therapy Key Players Head office and Products Offered
Table 32. Cell and Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Mergers & Acquisitions, Expansion
Table 35. Global Cell and Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Global Cell and Gene Therapy Market Size Market Share by Region (2021-2026)
Table 37. Global Cell and Gene Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 38. Global Cell and Gene Therapy Revenue Market Share by Country/Region (2021-2026)
Table 39. Americas Cell and Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 40. Americas Cell and Gene Therapy Market Size Market Share by Country (2021-2026)
Table 41. Americas Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 42. Americas Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Table 43. Americas Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 44. Americas Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Table 45. APAC Cell and Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 46. APAC Cell and Gene Therapy Market Size Market Share by Region (2021-2026)
Table 47. APAC Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 48. APAC Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 49. Europe Cell and Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 50. Europe Cell and Gene Therapy Market Size Market Share by Country (2021-2026)
Table 51. Europe Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 52. Europe Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 53. Middle East & Africa Cell and Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 54. Middle East & Africa Cell and Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 55. Middle East & Africa Cell and Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 56. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy
Table 57. Key Market Challenges & Risks of Cell and Gene Therapy
Table 58. Key Industry Trends of Cell and Gene Therapy
Table 59. Global Cell and Gene Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 60. Global Cell and Gene Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 61. Global Cell and Gene Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 62. Global Cell and Gene Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 63. Amgen Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 64. Amgen Inc. Cell and Gene Therapy Product Offered
Table 65. Amgen Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Amgen Inc. Main Business
Table 67. Amgen Inc. Latest Developments
Table 68. Dendreon Pharmaceuticals LLC. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 69. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
Table 70. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Dendreon Pharmaceuticals LLC. Main Business
Table 72. Dendreon Pharmaceuticals LLC. Latest Developments
Table 73. Fibrocell Science, Inc Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 74. Fibrocell Science, Inc Cell and Gene Therapy Product Offered
Table 75. Fibrocell Science, Inc Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Fibrocell Science, Inc Main Business
Table 77. Fibrocell Science, Inc Latest Developments
Table 78. Lonza Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 79. Lonza Cell and Gene Therapy Product Offered
Table 80. Lonza Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Lonza Main Business
Table 82. Lonza Latest Developments
Table 83. Charles River Laboratories Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 84. Charles River Laboratories Cell and Gene Therapy Product Offered
Table 85. Charles River Laboratories Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Charles River Laboratories Main Business
Table 87. Charles River Laboratories Latest Developments
Table 88. Cytiva Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 89. Cytiva Cell and Gene Therapy Product Offered
Table 90. Cytiva Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Cytiva Main Business
Table 92. Cytiva Latest Developments
Table 93. Catalent Biologics Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 94. Catalent Biologics Cell and Gene Therapy Product Offered
Table 95. Catalent Biologics Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Catalent Biologics Main Business
Table 97. Catalent Biologics Latest Developments
Table 98. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 99. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Product Offered
Table 100. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. FUJIFILM Diosynth Biotechnologies Main Business
Table 102. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 103. Made Scientific Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 104. Made Scientific Cell and Gene Therapy Product Offered
Table 105. Made Scientific Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Made Scientific Main Business
Table 107. Made Scientific Latest Developments
Table 108. AGC Biologics Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 109. AGC Biologics Cell and Gene Therapy Product Offered
Table 110. AGC Biologics Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. AGC Biologics Main Business
Table 112. AGC Biologics Latest Developments
Table 113. Pfizer CentreOne Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 114. Pfizer CentreOne Cell and Gene Therapy Product Offered
Table 115. Pfizer CentreOne Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Pfizer CentreOne Main Business
Table 117. Pfizer CentreOne Latest Developments
Table 118. Samsung Biologics Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 119. Samsung Biologics Cell and Gene Therapy Product Offered
Table 120. Samsung Biologics Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Samsung Biologics Main Business
Table 122. Samsung Biologics Latest Developments
Table 123. Kite Pharma, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 124. Kite Pharma, Inc. Cell and Gene Therapy Product Offered
Table 125. Kite Pharma, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Kite Pharma, Inc. Main Business
Table 127. Kite Pharma, Inc. Latest Developments
Table 128. Kolon TissueGene, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 129. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
Table 130. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Kolon TissueGene, Inc. Main Business
Table 132. Kolon TissueGene, Inc. Latest Developments
Table 133. Novartis AG Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 134. Novartis AG Cell and Gene Therapy Product Offered
Table 135. Novartis AG Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Novartis AG Main Business
Table 137. Novartis AG Latest Developments
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Gene Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Gene Therapy Sales Market Share by Country/Region (2025)
Figure 8. Cell and Gene Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Gene Therapy Market Size Market Share by Type in 2025
Figure 10. Global Cell and Gene Therapy Market Size Market Share by Cell Source in 2025
Figure 11. Global Cell and Gene Therapy Market Size Market Share by Technology in 2025
Figure 12. Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies
Figure 13. Global Cell and Gene Therapy Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Cell and Gene Therapy in Research and Academic Institutions
Figure 15. Global Cell and Gene Therapy Market: Research and Academic Institutions (2021-2026) & ($ millions)
Figure 16. Cell and Gene Therapy in Contract Research Organizations (CROs)
Figure 17. Global Cell and Gene Therapy Market: Contract Research Organizations (CROs) (2021-2026) & ($ millions)
Figure 18. Cell and Gene Therapy in Hospital
Figure 19. Global Cell and Gene Therapy Market: Hospital (2021-2026) & ($ millions)
Figure 20. Cell and Gene Therapy in Others
Figure 21. Global Cell and Gene Therapy Market: Others (2021-2026) & ($ millions)
Figure 22. Global Cell and Gene Therapy Market Size Market Share by Application in 2025
Figure 23. Global Cell and Gene Therapy Revenue Market Share by Player in 2025
Figure 24. Global Cell and Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 25. Americas Cell and Gene Therapy Market Size 2021-2026 ($ millions)
Figure 26. APAC Cell and Gene Therapy Market Size 2021-2026 ($ millions)
Figure 27. Europe Cell and Gene Therapy Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Cell and Gene Therapy Market Size 2021-2026 ($ millions)
Figure 29. Americas Cell and Gene Therapy Value Market Share by Country in 2025
Figure 30. United States Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Cell and Gene Therapy Market Size Market Share by Region in 2025
Figure 35. APAC Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 36. APAC Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 37. China Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. India Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Cell and Gene Therapy Market Size Market Share by Country in 2025
Figure 44. Europe Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Europe Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Germany Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. France Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 60. APAC Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 61. Europe Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 63. United States Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 64. Canada Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 65. Mexico Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 66. Brazil Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 67. China Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 68. Japan Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 69. Korea Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 71. India Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 72. Australia Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 73. Germany Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 74. France Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 75. UK Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 76. Italy Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 77. Russia Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 78. Egypt Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 79. South Africa Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 80. Israel Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 81. Turkey Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 82. Global Cell and Gene Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Cell and Gene Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 1. Cell and Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Gene Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Gene Therapy Sales Market Share by Country/Region (2025)
Figure 8. Cell and Gene Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Gene Therapy Market Size Market Share by Type in 2025
Figure 10. Global Cell and Gene Therapy Market Size Market Share by Cell Source in 2025
Figure 11. Global Cell and Gene Therapy Market Size Market Share by Technology in 2025
Figure 12. Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies
Figure 13. Global Cell and Gene Therapy Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Cell and Gene Therapy in Research and Academic Institutions
Figure 15. Global Cell and Gene Therapy Market: Research and Academic Institutions (2021-2026) & ($ millions)
Figure 16. Cell and Gene Therapy in Contract Research Organizations (CROs)
Figure 17. Global Cell and Gene Therapy Market: Contract Research Organizations (CROs) (2021-2026) & ($ millions)
Figure 18. Cell and Gene Therapy in Hospital
Figure 19. Global Cell and Gene Therapy Market: Hospital (2021-2026) & ($ millions)
Figure 20. Cell and Gene Therapy in Others
Figure 21. Global Cell and Gene Therapy Market: Others (2021-2026) & ($ millions)
Figure 22. Global Cell and Gene Therapy Market Size Market Share by Application in 2025
Figure 23. Global Cell and Gene Therapy Revenue Market Share by Player in 2025
Figure 24. Global Cell and Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 25. Americas Cell and Gene Therapy Market Size 2021-2026 ($ millions)
Figure 26. APAC Cell and Gene Therapy Market Size 2021-2026 ($ millions)
Figure 27. Europe Cell and Gene Therapy Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Cell and Gene Therapy Market Size 2021-2026 ($ millions)
Figure 29. Americas Cell and Gene Therapy Value Market Share by Country in 2025
Figure 30. United States Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Cell and Gene Therapy Market Size Market Share by Region in 2025
Figure 35. APAC Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 36. APAC Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 37. China Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. India Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Cell and Gene Therapy Market Size Market Share by Country in 2025
Figure 44. Europe Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Europe Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Germany Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. France Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Cell and Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 60. APAC Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 61. Europe Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 63. United States Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 64. Canada Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 65. Mexico Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 66. Brazil Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 67. China Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 68. Japan Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 69. Korea Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 71. India Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 72. Australia Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 73. Germany Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 74. France Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 75. UK Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 76. Italy Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 77. Russia Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 78. Egypt Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 79. South Africa Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 80. Israel Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 81. Turkey Cell and Gene Therapy Market Size 2027-2032 ($ millions)
Figure 82. Global Cell and Gene Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Cell and Gene Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Cell and Gene Therapy Market Size 2027-2032 ($ millions)
